Norditropin (somatropin) / Novo Nordisk 
Welcome,         Profile    Billing    Logout  
 90 Diseases   16 Trials   16 Trials   383 News 
25 Trials

   

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
Norditropin (somatropin) / Novo Nordisk
2013-003100-39: National SGA study Landelijke SGA studie

Ongoing
4
300
Europe
Somatropin, H01AC01, Solution for injection, Norditropin, Humatrope, Genotropin
Dutch Growth Research Foundation, Dutch Growth Research Foundation
Children who are born small for gestational age, defined as a birth length and/or birth weight < -2 SD score, who fail to show catch-up growth (short stature)., short stature kleine lengte, Diseases [C] - Hormonal diseases [C19]
 
 
2005-001507-19: Treatment with recombinant Growth Hormone in Children born Small for Gestational Age (SGA) without Catch-up Growth.

Ongoing
4
50
Europe
Norditropin® SimpleXx®, Growth Hormone, Norditropin® SimpleXx®, Norditropin® SimpleXx®
National Children\'s Hospital & Trinity College Dublin
Short stature in children born small for gestational age without catch up growth
 
 
2004-004292-11: Discontinuation of long-term GH replacement therapy - a randomised, placebo controlled trial in adult GH deficiency.

Ongoing
4
60
Europe
Norditropin SimplexX, NA, Norditropin SimplexX (5mg/1,5 ml) (INN:somatropin), Norditropin SimplexX (5mg/1,5 ml) (INN:somatropin)
Endocrine Department, Sahlgrenska University Hospital
This is a study in growth hormone deficient adult patients on stable growth hormone therapy of discountinuate growth hormone (GH) for 4 months in double blinded crossover, palcebo/controlled, randomised study design.
 
 
2004-002507-32: Effect of recombinant growth hormone on growth and chondrocyte dynamics in children with Inflammatory bowel disease (IBD) and growth failure.

Ongoing
4
60
Europe
Norditropin SimpleXx, Norditropin® SimpleXx® 5mg/1.5ml, Norditropin® SimpleXx® 5mg/1.5ml
Royal Hospital For Sick Children, Yorkhill Division
Growth retardation secondary to inflammatory bowel disease in children
 
 
2007-002224-15: Individual GH dosing using 1st year GH responsiveness for prepubertal growth response in short GHD/ISS children

Ongoing
3/4
100
Europe
Norditropin Simplex (R)/ Nordiflex (R), Powder and solvent for solution for injection, Norditropin SimpleXX (R)/ Nordiflex (R)
Göteborgs Universitet
GHD+ISS in prepubertal children born at term or prematurely, AGA or SGAGHD and SGA children (phase IV study)ISS children (phase III study)
 
 
2004-004727-36: Influence of low-dose i.v. growth hormone treatment together with glutamine supplementation in late-phase critically ill patient after multiple injury. A pilot study.

Ongoing
3
30
Europe
Norditropin Simplexx, 56/223/01-C, Solution for injection, Norditropin Simplexx
Charles University, 3rd Faculty of Medicine
Prolonged phase of critical illness after severe multiple trauma
 
 
REAL4, NCT03811535 / 2018-000231-27: A Research Study in Children With a Low Level of Hormone to Grow. Treatment is Somapacitan Once a Week Compared to Norditropin® Once a Day

Active, not recruiting
3
200
Europe, Canada, Japan, US, RoW
Somapacitan, Norditropin®
Novo Nordisk A/S
Growth Hormone Deficiency in Children
11/21
09/25
2021-005607-13: A research study to compare somapacitan once a week with Norditropin® once a day in children who need help to grow

Ongoing
3
395
Europe, RoW
somapacitan 5 mg/1.5 mL PDS290, Somapacitan 15 mg/1.5 mL PDS290, Solution for injection in pre-filled pen, Sogroya 10 mg/1.5 mL solution for injection in pre-filled pen, Norditropin FlexPro 10 mg/1.5 ml, solution for injection in pre-filled pen
Novo Nordisk A/S, Novo Nordisk A/S
Short stature born small for gestational age Turner syndromeNoonan syndromeIdiopathic short stature, Short stature born small for gestational age Turner syndromeNoonan syndromeIdiopathic short stature, Diseases [C] - Hormonal diseases [C19]
 
 
2020-002974-28: A research study in Chinese children with a low level of hormone to grow. Treatment is somapacitan once a week compared to Norditropin® once a day.

Not yet recruiting
3
110
RoW
Sogroya 15 mg/1.5 mL PDS290, Solution for injection, Solution for injection in pre-filled pen, Sogroya 10 mg/1.5 mL solution for injection in pre-filled pen, Norditropin FlexPro 10 mg/1.5 ml, solution for injection in pre-filled pen, Sogroya 5 mg/1.5 mL solution for injection in pre-filled pen
Novo Nordisk A/S, Novo Nordisk A/S
Growth hormone deficiency in children, Growth hormone deficiency in children, Diseases [C] - Hormonal diseases [C19]
 
 
NCT04633057: A Study to Evaluating the Efficacy and Safety of Recombinant Long-acting Human Growth Hormone (TJ101) in Children With Growth Hormone Deficiency

Completed
3
168
RoW
TJ101, NordiFlex
TJ Biopharma Co., Ltd.
Pediatric Growth Hormone Deficiency
07/23
07/23
NCT04970654 / 2020-002974-28: A Research Study in Chinese Children With a Low Level of Hormone to Grow. Treatment is Somapacitan Once a Week Compared to Norditropin® Once a Day.

Completed
3
110
RoW
somapacitan, Norditropin®
Novo Nordisk A/S, Novo Nordisk A/S
Growth Hormone Deficiency in Children
11/23
12/23
REAL 8, NCT05330325 / 2021-005607-13: A Research Study to Compare Somapacitan Once a Week With Norditropin® Once a Day in Children Who Need Help to Grow

Active, not recruiting
3
399
Europe, Canada, Japan, US, RoW
Somapacitan, Norditropin®
Novo Nordisk A/S, Novo Nordisk A/S
SGA, Turner Syndrome, Noonan Syndrome, ISS
08/24
10/27
NCT06103513: Randomized Clinical Trial of Two Different Initial Growth Hormone Doses in Children

Recruiting
3
50
US
Somatropin, Norditropin, Nutropin AQ, Genotropin, Zomacton, Humatrope, Omnitrope.
Northwell Health
Growth Disorders, Growth Failure, Growth Hormone Treatment, Growth
06/25
12/25
NCT04513171: Safety and Efficacy of Y-shape Pegylated Somatropin in Growth Hormone Deficiency Children

Completed
2/3
434
RoW
Y-shape pegylated somatropin, Norditropin®, Norditropin
Xiamen Amoytop Biotech Co., Ltd., Tongji Hospital
Growth Hormone Deficiency
06/23
07/23
2020-000874-92: A Multicenter, 24-Month, Randomized, Open-Label, Active Control, Parallel Arm, Phase 2 Study of Daily Oral LUM-201 in Naïve-to-Treatment, Prepubertal Children with Idiopathic Growth Hormone Deficiency (GHD) Wieloośrodkowe, 24-miesięczne, Randomizowane, Otwarte, Kontrolowane, Równoramienne Badanie Fazy 2 z Podawanym Codziennie Doustnie LUM-201 Dzieciom Wcześniej Nieleczonym w Okresie Przedpokwitaniowym z Idiopatycznym Niedoborem Hormonu Wzrostu (GHD).

Not yet recruiting
2
80
Europe
LUM-201, Tablet, Injection, Norditropin
Lumos Pharma, Inc., Lumos Pharma
Growth hormone deficiency, Growth hormone deficiency, Diseases [C] - Hormonal diseases [C19]
 
 
NCT03878446 / 2018-000232-10: A Research Study in Children Born Small and Who Stayed Small. Treatment is Somapacitan Once a Week Compared to Norditropin® Once a Day

Active, not recruiting
2
62
Europe, Japan, US, RoW
Somapacitan, Norditropin®
Novo Nordisk A/S
Short Stature Children Born Small for Gestational Age (SGA)
05/21
12/26
OraGrowtH210, NCT04614337 / 2020-000874-92: Phase 2 Study of LUM-201 in Children With Growth Hormone Deficiency ( Trial)

Completed
2
82
Europe, US, RoW
LUM-201, rhGH Norditropin® pen (34 µg/kg)
Lumos Pharma, Lumos Pharma
Growth Hormone Deficiency
09/24
09/24
NCT02616562 / 2015-000531-32: Investigating Efficacy and Safety of Once-weekly NNC0195-0092 (Somapacitan) Treatment Compared to Daily Growth Hormone Treatment (Norditropin® FlexPro®) in Growth Hormone Treatment naïve Pre-pubertal Children With Growth Hormone Deficiency

Completed
2
74
Europe, Japan, US, RoW
somapacitan, NNC0195-0092, Norditropin® FlexPro® pen
Novo Nordisk A/S
Growth Hormone Disorder, Growth Hormone Deficiency in Children
09/24
09/24
NCT04121780: Growth Hormone Replacement Therapy for Retried Professional Football Players

Recruiting
2
42
US
Growth Hormone, Norditropin® (somatropin [rDNA origin] injection), Placebo
Center for Neurological Studies, Novo Nordisk A/S
TBI (Traumatic Brain Injury), Concussion, Brain, Sport Injury, Anterior Pituitary Hyposecretion Syndrome, Hypopituitarism, Growth Hormone Deficiency
03/25
09/26
GWIT, NCT05355272: Growth Hormone Replacement in Veterans With GWI and AGHD

Recruiting
2
20
US
Recombinant human growth hormone, Somatropin, Genotropin, Humatrope, Norditropin
Baylor College of Medicine, United States Department of Defense
Gulf War Syndrome, Adult Growth Hormone Deficiency
05/25
09/25
NCT03288103: Growth Hormone Treatment in Patients With Aggrecan (ACAN) Deficiency

Completed
1/2
22
US
Norditropin, somatropin
Children's Hospital Medical Center, Cincinnati
Short Stature
03/23
08/23
NCT00663676: Growth Hormone Administration and the Human Immune System - I

Active, not recruiting
1
6
US
human recombinant growth hormone (Growth Hormone), Norditropin (somatropin, rDNA origin)
National Institute on Aging (NIA)
Aging, Immune System and Related Disorders
12/13
12/13
NCT04020913: Skeletal Muscle Effects of GH in Boys

Active, not recruiting
N/A
45
US
Somatropin injection, Recombinant Growth Hormone, Norditropin
Nemours Children's Clinic, Novo Nordisk A/S
Growth Hormone Deficiency, Idiopathic Short Stature
07/25
07/25
NCT05308927: French Registry of Children Treated With Norditropin® for Short Stature Associated With Noonan Syndrome

Enrolling by invitation
N/A
221
Europe
Norditropin, Somatropin
Novo Nordisk A/S
Noonan Syndrome
03/28
03/28
NCT03972345: Influence of Adherence to Growth Hormone Therapy (GHT) With Norditropin® on Near Final Height in Patients With Growth Hormone Deficiency (GHD) and Born Small for Gestational Age (SGA)

Enrolling by invitation
N/A
750
Europe
Norditropin® FlexPro®
Novo Nordisk A/S
Growth Hormone Deficiency in Children, Born Small for Gestational Age
06/29
06/31
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
Norditropin (somatropin) / Novo Nordisk
2013-003100-39: National SGA study Landelijke SGA studie

Ongoing
4
300
Europe
Somatropin, H01AC01, Solution for injection, Norditropin, Humatrope, Genotropin
Dutch Growth Research Foundation, Dutch Growth Research Foundation
Children who are born small for gestational age, defined as a birth length and/or birth weight < -2 SD score, who fail to show catch-up growth (short stature)., short stature kleine lengte, Diseases [C] - Hormonal diseases [C19]
 
 
2005-001507-19: Treatment with recombinant Growth Hormone in Children born Small for Gestational Age (SGA) without Catch-up Growth.

Ongoing
4
50
Europe
Norditropin® SimpleXx®, Growth Hormone, Norditropin® SimpleXx®, Norditropin® SimpleXx®
National Children\'s Hospital & Trinity College Dublin
Short stature in children born small for gestational age without catch up growth
 
 
2004-004292-11: Discontinuation of long-term GH replacement therapy - a randomised, placebo controlled trial in adult GH deficiency.

Ongoing
4
60
Europe
Norditropin SimplexX, NA, Norditropin SimplexX (5mg/1,5 ml) (INN:somatropin), Norditropin SimplexX (5mg/1,5 ml) (INN:somatropin)
Endocrine Department, Sahlgrenska University Hospital
This is a study in growth hormone deficient adult patients on stable growth hormone therapy of discountinuate growth hormone (GH) for 4 months in double blinded crossover, palcebo/controlled, randomised study design.
 
 
2004-002507-32: Effect of recombinant growth hormone on growth and chondrocyte dynamics in children with Inflammatory bowel disease (IBD) and growth failure.

Ongoing
4
60
Europe
Norditropin SimpleXx, Norditropin® SimpleXx® 5mg/1.5ml, Norditropin® SimpleXx® 5mg/1.5ml
Royal Hospital For Sick Children, Yorkhill Division
Growth retardation secondary to inflammatory bowel disease in children
 
 
2007-002224-15: Individual GH dosing using 1st year GH responsiveness for prepubertal growth response in short GHD/ISS children

Ongoing
3/4
100
Europe
Norditropin Simplex (R)/ Nordiflex (R), Powder and solvent for solution for injection, Norditropin SimpleXX (R)/ Nordiflex (R)
Göteborgs Universitet
GHD+ISS in prepubertal children born at term or prematurely, AGA or SGAGHD and SGA children (phase IV study)ISS children (phase III study)
 
 
2004-004727-36: Influence of low-dose i.v. growth hormone treatment together with glutamine supplementation in late-phase critically ill patient after multiple injury. A pilot study.

Ongoing
3
30
Europe
Norditropin Simplexx, 56/223/01-C, Solution for injection, Norditropin Simplexx
Charles University, 3rd Faculty of Medicine
Prolonged phase of critical illness after severe multiple trauma
 
 
REAL4, NCT03811535 / 2018-000231-27: A Research Study in Children With a Low Level of Hormone to Grow. Treatment is Somapacitan Once a Week Compared to Norditropin® Once a Day

Active, not recruiting
3
200
Europe, Canada, Japan, US, RoW
Somapacitan, Norditropin®
Novo Nordisk A/S
Growth Hormone Deficiency in Children
11/21
09/25
2021-005607-13: A research study to compare somapacitan once a week with Norditropin® once a day in children who need help to grow

Ongoing
3
395
Europe, RoW
somapacitan 5 mg/1.5 mL PDS290, Somapacitan 15 mg/1.5 mL PDS290, Solution for injection in pre-filled pen, Sogroya 10 mg/1.5 mL solution for injection in pre-filled pen, Norditropin FlexPro 10 mg/1.5 ml, solution for injection in pre-filled pen
Novo Nordisk A/S, Novo Nordisk A/S
Short stature born small for gestational age Turner syndromeNoonan syndromeIdiopathic short stature, Short stature born small for gestational age Turner syndromeNoonan syndromeIdiopathic short stature, Diseases [C] - Hormonal diseases [C19]
 
 
2020-002974-28: A research study in Chinese children with a low level of hormone to grow. Treatment is somapacitan once a week compared to Norditropin® once a day.

Not yet recruiting
3
110
RoW
Sogroya 15 mg/1.5 mL PDS290, Solution for injection, Solution for injection in pre-filled pen, Sogroya 10 mg/1.5 mL solution for injection in pre-filled pen, Norditropin FlexPro 10 mg/1.5 ml, solution for injection in pre-filled pen, Sogroya 5 mg/1.5 mL solution for injection in pre-filled pen
Novo Nordisk A/S, Novo Nordisk A/S
Growth hormone deficiency in children, Growth hormone deficiency in children, Diseases [C] - Hormonal diseases [C19]
 
 
NCT04633057: A Study to Evaluating the Efficacy and Safety of Recombinant Long-acting Human Growth Hormone (TJ101) in Children With Growth Hormone Deficiency

Completed
3
168
RoW
TJ101, NordiFlex
TJ Biopharma Co., Ltd.
Pediatric Growth Hormone Deficiency
07/23
07/23
NCT04970654 / 2020-002974-28: A Research Study in Chinese Children With a Low Level of Hormone to Grow. Treatment is Somapacitan Once a Week Compared to Norditropin® Once a Day.

Completed
3
110
RoW
somapacitan, Norditropin®
Novo Nordisk A/S, Novo Nordisk A/S
Growth Hormone Deficiency in Children
11/23
12/23
REAL 8, NCT05330325 / 2021-005607-13: A Research Study to Compare Somapacitan Once a Week With Norditropin® Once a Day in Children Who Need Help to Grow

Active, not recruiting
3
399
Europe, Canada, Japan, US, RoW
Somapacitan, Norditropin®
Novo Nordisk A/S, Novo Nordisk A/S
SGA, Turner Syndrome, Noonan Syndrome, ISS
08/24
10/27
NCT06103513: Randomized Clinical Trial of Two Different Initial Growth Hormone Doses in Children

Recruiting
3
50
US
Somatropin, Norditropin, Nutropin AQ, Genotropin, Zomacton, Humatrope, Omnitrope.
Northwell Health
Growth Disorders, Growth Failure, Growth Hormone Treatment, Growth
06/25
12/25
NCT04513171: Safety and Efficacy of Y-shape Pegylated Somatropin in Growth Hormone Deficiency Children

Completed
2/3
434
RoW
Y-shape pegylated somatropin, Norditropin®, Norditropin
Xiamen Amoytop Biotech Co., Ltd., Tongji Hospital
Growth Hormone Deficiency
06/23
07/23
2020-000874-92: A Multicenter, 24-Month, Randomized, Open-Label, Active Control, Parallel Arm, Phase 2 Study of Daily Oral LUM-201 in Naïve-to-Treatment, Prepubertal Children with Idiopathic Growth Hormone Deficiency (GHD) Wieloośrodkowe, 24-miesięczne, Randomizowane, Otwarte, Kontrolowane, Równoramienne Badanie Fazy 2 z Podawanym Codziennie Doustnie LUM-201 Dzieciom Wcześniej Nieleczonym w Okresie Przedpokwitaniowym z Idiopatycznym Niedoborem Hormonu Wzrostu (GHD).

Not yet recruiting
2
80
Europe
LUM-201, Tablet, Injection, Norditropin
Lumos Pharma, Inc., Lumos Pharma
Growth hormone deficiency, Growth hormone deficiency, Diseases [C] - Hormonal diseases [C19]
 
 
NCT03878446 / 2018-000232-10: A Research Study in Children Born Small and Who Stayed Small. Treatment is Somapacitan Once a Week Compared to Norditropin® Once a Day

Active, not recruiting
2
62
Europe, Japan, US, RoW
Somapacitan, Norditropin®
Novo Nordisk A/S
Short Stature Children Born Small for Gestational Age (SGA)
05/21
12/26
OraGrowtH210, NCT04614337 / 2020-000874-92: Phase 2 Study of LUM-201 in Children With Growth Hormone Deficiency ( Trial)

Completed
2
82
Europe, US, RoW
LUM-201, rhGH Norditropin® pen (34 µg/kg)
Lumos Pharma, Lumos Pharma
Growth Hormone Deficiency
09/24
09/24
NCT02616562 / 2015-000531-32: Investigating Efficacy and Safety of Once-weekly NNC0195-0092 (Somapacitan) Treatment Compared to Daily Growth Hormone Treatment (Norditropin® FlexPro®) in Growth Hormone Treatment naïve Pre-pubertal Children With Growth Hormone Deficiency

Completed
2
74
Europe, Japan, US, RoW
somapacitan, NNC0195-0092, Norditropin® FlexPro® pen
Novo Nordisk A/S
Growth Hormone Disorder, Growth Hormone Deficiency in Children
09/24
09/24
NCT04121780: Growth Hormone Replacement Therapy for Retried Professional Football Players

Recruiting
2
42
US
Growth Hormone, Norditropin® (somatropin [rDNA origin] injection), Placebo
Center for Neurological Studies, Novo Nordisk A/S
TBI (Traumatic Brain Injury), Concussion, Brain, Sport Injury, Anterior Pituitary Hyposecretion Syndrome, Hypopituitarism, Growth Hormone Deficiency
03/25
09/26
GWIT, NCT05355272: Growth Hormone Replacement in Veterans With GWI and AGHD

Recruiting
2
20
US
Recombinant human growth hormone, Somatropin, Genotropin, Humatrope, Norditropin
Baylor College of Medicine, United States Department of Defense
Gulf War Syndrome, Adult Growth Hormone Deficiency
05/25
09/25
NCT03288103: Growth Hormone Treatment in Patients With Aggrecan (ACAN) Deficiency

Completed
1/2
22
US
Norditropin, somatropin
Children's Hospital Medical Center, Cincinnati
Short Stature
03/23
08/23
NCT00663676: Growth Hormone Administration and the Human Immune System - I

Active, not recruiting
1
6
US
human recombinant growth hormone (Growth Hormone), Norditropin (somatropin, rDNA origin)
National Institute on Aging (NIA)
Aging, Immune System and Related Disorders
12/13
12/13
NCT04020913: Skeletal Muscle Effects of GH in Boys

Active, not recruiting
N/A
45
US
Somatropin injection, Recombinant Growth Hormone, Norditropin
Nemours Children's Clinic, Novo Nordisk A/S
Growth Hormone Deficiency, Idiopathic Short Stature
07/25
07/25
NCT05308927: French Registry of Children Treated With Norditropin® for Short Stature Associated With Noonan Syndrome

Enrolling by invitation
N/A
221
Europe
Norditropin, Somatropin
Novo Nordisk A/S
Noonan Syndrome
03/28
03/28
NCT03972345: Influence of Adherence to Growth Hormone Therapy (GHT) With Norditropin® on Near Final Height in Patients With Growth Hormone Deficiency (GHD) and Born Small for Gestational Age (SGA)

Enrolling by invitation
N/A
750
Europe
Norditropin® FlexPro®
Novo Nordisk A/S
Growth Hormone Deficiency in Children, Born Small for Gestational Age
06/29
06/31

Download Options